John Simard

CIK: 0001639078

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

XBIT

XBiotech Inc.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (3 total)

XBIT
XBiotech Inc.
Oct 26, 2026
Purchase(P)
Direct
368.5K shares at avg. $1.93$711K
XBIT
XBiotech Inc.
Mar 17, 2025
Award(A)
Stock Option
Direct
1M shares-
XBIT
XBiotech Inc.
Jan 31, 2025
Other(J)
Convertible Loan Agreement
Direct
2.5M shares at avg. $10000000.00-

		Type	Shares	Price		Ownership
Oct 26, 2026	XBIT XBiotech Inc.	Purchase(P)	368,524	$1.93	$711,251	Direct
Mar 17, 2025	XBIT XBiotech Inc.	Award(A) Stock Option	1,026,228	-	-	Direct
Jan 31, 2025	XBIT XBiotech Inc.	Other(J) Convertible Loan Agreement	2,470,355	$10000000.00	-	Direct

1-3 of 3 transactions

About SIMARD JOHN

SIMARD JOHN (SEC CIK 0001639078) files insider reports with the SEC as Director of XBiotech Inc. (XBIT).

Signal8 holds 3 ownership filings by SIMARD JOHN, all Form 4s, filed between Feb 4, 2025 and Oct 28, 2026. Those filings report 3 transactions, from Jan 31, 2025 to Oct 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on SIMARD JOHN's filings is in AUSTIN, TX.

Recent filings by SIMARD JOHN

Oct 26, 2026: Open-market purchase of XBIT shares (Form 4, code P).
Mar 17, 2025: Grant or award of XBIT derivative securities (Form 4, code A).
Jan 31, 2025: Other transaction of XBIT derivative securities (Form 4, code J).

Other insiders filing for XBiotech Inc. (XBIT)

Simard Jan-Paul, Co-Chief Executive Officer
Rademaker Craig Evan, Director
Soffer David Spencer, Director
Kuendig Thomas Martin, Director
Troy Tevi David, Director

How to read Form 4 transaction codes